Close similarity between cultured human omental mesothelial cells and endothelial cells in cytochemical markers and plasminogen activator production
Tóm tắt
The mesothelial cells obtained from human omental adipose tissue showed a typical cobblestone monolayer and reacted strongly with keratin, but did not have Von Willebrand factor. Ultrastructurally these cells revealed the existence of desmosome-like cell junctions as well as intracellular canaliculi, tubular structures surrounded by microvilli, and tonofilament-like filaments. The mesothelial cells grew much faster in the medium containing epidermal growth factor, actively took up acetylated-low density lipoprotein into their cytoplasm, and released angiotensin-converting enzyme. They also released urokinase-type plasminogen activator, but only half as much as do human umbilical vein endothelial cells; release of tissue-type plasminogen activator was not observed. Inasmuch as the mesothelial cells also released plasminogen activator inhibitor-1, as do human umbilical vein endothelial cells, we could not detect u-PA activity in culture medium. u-PA may play a role in the protection against adhesion among visceral organs. These observations indicate that cultured human mesothelial cells have characteristics closely related to those found in human endothelial cells.
Tài liệu tham khảo
Booyse, F. M.; Osikowicz, G.; Feder, S., et al. isolation and characterization of a urokinase-type plasminogen activator (Mr = 54 000) from cultured human endothelial cells indistinguishable from urinary urokinase. J. Biol. Chem. 259:7198–7205; 1984.
Buckman, R. F.; Woods, M.; Sargent, L., et al. A unifying pathogenetic mechanism in the etiology of intraperitoneal adhesions. J. Surg. Res. 20:1–5; 1976.
Chung-Welch, N.; Patton, W. F.; Yen-Patton, G. P. A., et al. Phenotypic comparison between mesothelial and microvascular endothelial cell lineages using conventional endothelial cell markers, cytoskeletal protein markers and in vitro assays of angiogenic potential. Differentiation 42:44–53; 1989.
Cicila, G. T.; O’Connell, T. M.; Hahn, W. C., et al. Cloned cDNA sequence for the human mesothelial protein “mesosecrin” discloses its identity as a plasminogen activator inhibitor (PAI-1) and a recent evolutionary change in transcript processing. J. Cell Sci. 94:1–10; 1989.
Connell, N. D.; Rheinwald, J. G. Regulation of the cytoskeleton in mesothelial cells: reversible loss of keratin and increase in vimentin during rapid growth in culture. Cell 34:245–253; 1983.
Collen, D. On the regulation and control of fibrinolysis. Thromb. Haemostasis 43:77–89; 1980.
Dano, K.; Andreasen, P. A.; Grondahl-Hansen, J., et al. Plasminogen activators, tissue degradation, and cancer. Adv. Cancer Res. 44:139–266; 1985.
Hau, T.; Ahrenholz, D. H.; Simmons, R. L. Secondary bacterial peritonitis: the biologic basis of treatment. Curr. Probl. Surg. 260:1–65; 1979.
Hayes, L. W.; Goguen, C. A.; Ching, S.-F., et al. Angiotensin-converting enzyme: accumulation in medium from cultured endothelial cells. Biochem. Biophys. Res. Commun. 82:1147–1153; 1978.
Hesseldahl, H.; Larsen, J. F. Ultrastructure of human yolk sac: endoderm, mesenchyme, tubules and mesothelium. Am. J. Anat. 126:315–336; 1969.
Husain, S. S.; Hasan, A. A. K.; Budzynski, A. Z. Differences between binding of one-chain and two-chain tissue plasminogen activators to non-cross-linked and cross-linked fibrin clots. Blood 74:999–1006; 1989.
Jaffe, E. A.; Nachman, R. L.; Becker, C. G. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J. Clin. Invest. 52:2745–2756; 1973.
Kasai, S.; Arimura, H.; Nishida, M., et al. Proteolytic cleavage of single-chain pro-urokinase induces conformational change which follows activation of the zymogen and reduction of its high affinity for fibrin. J. Biol. Chem. 260:12377–12381; 1985.
Levin, E. G. Latent tissue plasminogen activator produced by human endothelial cells in culture: evidence for an enzyme-inhibitor complex. Proc. Natl. Acad. Sci. USA 80:6804–6808; 1983.
Mackay, B.; Bennington, J. L.; Skoglund, R. W. The adenomatoid tumor: fine structural evidence for a mesothelial origin. Cancer 27:109–115; 1971.
Maruyama, Y. The human endothelial cell tissue culture. Z. Zellforsch. Microsk. Anat. 60:69–79; 1963.
Mukai, K.; Rosai, J.; Burgdorf, W. H. C. Localization of factor VIII-related antigen in vascular endothelial cells using an immunoperoxidase method. Am. J. Surg. Pathol. 4:273–276; 1980.
Nielsen, L. S.; Hansen, J. G.; Skriver, L., et al. Purification of zymogen to plasminogen activator from human glioblastoma cells by affinity chromatography with monoclonal antibody. Biochemistry 21:6410–6415; 1982.
Pepper, M. S.; Vassalli, J.-D.; Montesano, R., et al. Urokinase-type plasminogen activator is induced in migrating capillary endothelial cells. J. Cell Biol. 105:2535–2541; 1987.
Philips, M.; Juul, A.-G.; Thorsen, S. Human endothelial cells produce a plasminogen activator inhibitor and a tissue-type plasminogen activator-inhibitor complex. Biochim. Biophys. Acta 802:99–110; 1984.
Rheinwald, J. G.; Green, H. Serial cultivation of strains of human epidermal keratinocytes: the formation of keratinizing colonies from single cells. Cell 6:331–344; 1975.
Rheinwald, J. G.; Jorgensen, J. L.; Hahn, W. C., et al. Mesosecrin: a secreted glycoprotein produced in abundance by human mesothelial, endothelial, and kidney epithelial cells in culture. J. Cell Biol. 104:263–275; 1987.
Sprengers, E. D.; Verheijen, J. H.; Van Hinsbergh, V. W. M., et al. Evidence for the presence of two different fibrinolytic inhibitors in human endothelial cell conditioned medium. Biochim. Biophys. Acta. 801:163–170; 1984.
Suzuki, K.; Sakata, N.; Kitani, A., et al. Characterization of human monocytic cell line, U937, in taking up acetylated low-density lipoprotein and cholesteryl ester accumulation. A flow cytometric and HPLC study. Biochim. Biophys. Acta. 1042:210–216; 1990.
Takahashi, K.; Sawasaki, Y.; Hata, J., et al. Cobblestone monolayer cells from human omental adipose tissue are possibly mesothelial, not endothelial. In Vitro Cell. Dev. Biol. 25:109–111; 1989.
Takahashi, K.; Sawasaki, Y.; Hata, J., et al. Spontaneous transformation and immortalization of human endothelial cells. In Vitro Cell. Dev. Biol. 26:265–274; 1990.
Van Hinsbergh, V. W. M.; Binnema, D.; Scheffer, M. A., et al. Production of plasminogen activators and inhibitor by serially propagated endothelial cells from adult human blood vessels. Arteriosclerosis 7:389–400; 1987.
Van Hinsbergh, V. W. M.; Sprengers, E. D.; Kooistra, T. Effect of thrombin on the production of plasminogen activators and PA inhibitor-1 by human foreskin microvascular endothelial cells. Thromb. Haemostasis 57:148–153; 1987.
Voyta, J. C.; Via, D. P.; Butterfield, C. E., et al. Identification and isolation of endothelial cells based on their increased uptake of acetylated-low density lipoprotein. J. Cell Biol. 99:2034–2040; 1984.
Whitaker, D.; Papadimitriou, J. M.; Walters, M. N.-I. The mesothelium: its fibrinolytic properties. J. Pathol. 136:291–299; 1982.
Wu, Y.-J.; Parker, L. M.; Binder, N. E., et al. The mesothelial keratins: a new family of cytoskeletal proteins identified in cultured mesothelial cells and nonkeratinizing epithelia. Cell 31:693–703; 1982.
Wun, T.-C.; Ossowski, L.; Reich, E. A proenzyme form of human urokinase. J. Biol. Chem. 257:7262–7268; 1982.